Literature DB >> 18091364

cAMP and cGMP in human parotid saliva: relationships to taste and smell dysfunction, gender, and age.

Robert I Henkin1, Irina Velicu, A Papathanassiu.   

Abstract

Among the chemical moieties present in human parotid saliva, some, such as gustin or carbonic anhydrase VI, have been useful to distinguish patients with taste and smell dysfunction from normal subjects. To continue these studies we compared levels of salivary cAMP and cGMP in patients with taste and smell dysfunction with those in normal subjects. We were also interested in exploring physiological characteristics of salivary cAMP and cGMP including changes with gender and age because previous studies had not clearly defined these issues. To perform these studies parotid saliva was collected from 61 normal volunteers and 253 patients with taste and smell dysfunction. cAMP and cGMP were measured by a spectrophotometric 96 plate ELISA technique; parotid salivary protein and flow rate were also measured. Both cAMP and cGMP were found in saliva of normal subjects and patients in the detection range of the assay used. In patients mean concentrations of both cAMP and cGMP were lower than in normal subjects; for cAMP levels were lower among both men and women patients. cAMP was 7 to 10 times higher than cGMP in both normal subjects and patients. Concentrations of cAMP were consistently higher in normal women than in normal men. cAMP levels were generally lower and cGMP levels were generally higher than in previously reported studies. There was a complex pattern of change for both cAMP and cGMP with age with concentrations increasing to about age 50, then decreasing, then increasing again at age >70 years.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18091364     DOI: 10.1097/MAJ.0b013e3180de4d97

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  7 in total

1.  Biologically active substances-enriched diet regulates gonadotrope cell activation pathway in liver of adult and old rats.

Authors:  Hanna Oszkiel; Jacek Wilczak; Michał Jank
Journal:  Genes Nutr       Date:  2014-08-26       Impact factor: 5.523

2.  Erythrocyte membrane antigen frequencies in patients with Type II congenital smell loss.

Authors:  William A Stateman; Robert I Henkin; Alexandra B Knöppel; Willy A Flegel
Journal:  Am J Otolaryngol       Date:  2014-10-08       Impact factor: 1.808

3.  Carbonic anhydrase I, II, and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation.

Authors:  Robert I Henkin; Samuel J Potolicchio; Lucien M Levy; Ramy Moharram; Irina Velicu; Brian M Martin
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378

4.  Possible peripheral mechanism for taste disorder in rats administered S-1.

Authors:  Kumiko Aoki; Koji Obata; Miyako Kurihara; Hiroki Kuniyasu; Tadaaki Kirita; Miyako Takaki
Journal:  Int J Clin Oncol       Date:  2013-06-04       Impact factor: 3.402

5.  Central mechanisms in burning mouth syndrome involving the olfactory nerve: a preliminary study.

Authors:  Mariana Siviero; Manoel Jacobsen Teixeira; José Tadeu Tesseroli de Siqueira; Sílvia Regina Dowgan Tesseroli de Siqueira
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 6.  Interventions for managing taste disturbances.

Authors:  Sumanth Kumbargere Nagraj; Renjith P George; Naresh Shetty; David Levenson; Debra M Ferraiolo; Ashish Shrestha
Journal:  Cochrane Database Syst Rev       Date:  2017-12-20

Review 7.  Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review.

Authors:  Elnaz Khani; Sajad Khiali; Samineh Beheshtirouy; Taher Entezari-Maleki
Journal:  Eur J Pharmacol       Date:  2021-10-19       Impact factor: 4.432

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.